logo
logo

Qu Biologics Closes Usd$12M Equity Financing

Mar 21, 2022over 3 years ago

Amount Raised

$12 Million

Vancouver

Description

Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce the closing of a USD$12M equity financing to enable expansion of Qu’s team, initiation of an additional three Phase 2 clinical studies, and the acceleration of Qu’s novel immunomodulation platform.

Company Information

Company

Qu Biologics

Location

Vancouver, Washington, United States

FundzWatch™ Score

80
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech